Sepers MD et al. |
Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model. |
2018 |
J. Neurosci. |
pmid:29192125
|
Subbanna S et al. |
Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits. |
2013 |
J. Neurosci. |
pmid:23575834
|
Justinová Z et al. |
The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys. |
2011 |
J. Neurosci. |
pmid:21562266
|
Melis M et al. |
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats. |
2014 |
J. Neurosci. |
pmid:25232109
|
Ade KK and Lovinger DM |
Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. |
2007 |
J. Neurosci. |
pmid:17329438
|
Zhang SY et al. |
Endocannabinoid-dependent homeostatic regulation of inhibitory synapses by miniature excitatory synaptic activities. |
2009 |
J. Neurosci. |
pmid:19846710
|
Gubellini P et al. |
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. |
2002 |
J. Neurosci. |
pmid:12177188
|
Bajo M et al. |
Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands. |
2009 |
J. Neurosci. Res. |
pmid:18816788
|
Shinjyo N et al. |
Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system. |
2013 |
J. Neurosci. Res. |
pmid:23633391
|
Katz PS et al. |
Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury. |
2015 |
J. Neurotrauma |
pmid:25166905
|
Tchantchou F and Zhang Y |
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury. |
2013 |
J. Neurotrauma |
pmid:23151067
|
Mennella I et al. |
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans. |
2015 |
J. Nutr. |
pmid:26180248
|
Batetta B et al. |
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. |
2009 |
J. Nutr. |
pmid:19549757
|
Midtbø LK et al. |
Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic acid-derived oxylipins and ceramides in mice. |
2015 |
J. Nutr. Biochem. |
pmid:25776459
|
Hutchins-Wiese HL et al. |
Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle. |
2012 |
J. Nutr. Biochem. |
pmid:22051448
|
Kim J and Watkins BA |
Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity. |
2014 |
J. Nutr. Biochem. |
pmid:24854955
|
Liisberg U et al. |
Intake of a Western diet containing cod instead of pork alters fatty acid composition in tissue phospholipids and attenuates obesity and hepatic lipid accumulation in mice. |
2016 |
J. Nutr. Biochem. |
pmid:27155918
|
Duclos RI et al. |
A methodology for radiolabeling of the endocannabinoid 2-arachidonoylglycerol (2-AG). |
2011 |
J. Org. Chem. |
pmid:21370840
|
Chiba T et al. |
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. |
2011 |
J. Pharm. Pharmacol. |
pmid:21492165
|
Darmani NA |
The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:11752094
|
Kinsey SG et al. |
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. |
2009 |
J. Pharmacol. Exp. Ther. |
pmid:19502530
|
Wallace MJ et al. |
The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12954810
|
Lichtman AH et al. |
Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:12065702
|
Patel S et al. |
Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12808005
|
McDougle DR et al. |
Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase. |
2014 |
J. Pharmacol. Exp. Ther. |
pmid:25277139
|
Caprioli A et al. |
The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models. |
2012 |
J. Pharmacol. Exp. Ther. |
pmid:22514334
|
Kinsey SG et al. |
Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects. |
2013 |
J. Pharmacol. Exp. Ther. |
pmid:23412396
|
Ritter JK et al. |
Production and actions of the anandamide metabolite prostamide E2 in the renal medulla. |
2012 |
J. Pharmacol. Exp. Ther. |
pmid:22685343
|
Vannacci A et al. |
The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15187170
|
Lee M et al. |
Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7473135
|
Shoemaker JL et al. |
Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:16081674
|
Martin BR et al. |
Cannabinoid properties of methylfluorophosphonate analogs. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10945879
|
Shoemaker JL et al. |
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15901805
|
Pan B et al. |
Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling. |
2009 |
J. Pharmacol. Exp. Ther. |
pmid:19666749
|
Hillard CJ |
Endocannabinoids and vascular function. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10871291
|
Aaltonen N et al. |
In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048). |
2016 |
J. Pharmacol. Exp. Ther. |
pmid:27451409
|
Wilkerson JL et al. |
The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model. |
2016 |
J. Pharmacol. Exp. Ther. |
pmid:26791602
|
Leonard MZ et al. |
Cannabinoid CB Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors. |
2017 |
J. Pharmacol. Exp. Ther. |
pmid:28947487
|
Raman P et al. |
15-Deoxy-Δ¹²,¹â´-prostaglandin Jâ‚‚-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells. |
2012 |
J. Pharmacol. Exp. Ther. |
pmid:22700433
|
Giuffrida A et al. |
Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11408519
|
Burston JJ et al. |
N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18682568
|
Shimizu T et al. |
Stimulatory and inhibitory roles of brain 2-arachidonoylglycerol in bombesin-induced central activation of adrenomedullary outflow in rats. |
2013 |
J. Pharmacol. Sci. |
pmid:23386378
|
Sugiura T et al. |
New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation. |
2004 |
J. Pharmacol. Sci. |
pmid:15599096
|
Niki M et al. |
Modulation of sweet taste sensitivities by endogenous leptin and endocannabinoids in mice. |
2015 |
J. Physiol. (Lond.) |
pmid:25728242
|
Frazier CJ |
Key questions of endocannabinoid signalling in the CNS: which, where and when? |
2011 |
J. Physiol. (Lond.) |
pmid:22001725
|
Szabo B et al. |
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. |
2006 |
J. Physiol. (Lond.) |
pmid:16973696
|
Zhong P et al. |
Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum. |
2011 |
J. Physiol. (Lond.) |
pmid:21911610
|
Xu JY et al. |
Long-lasting potentiation of hippocampal synaptic transmission by direct cortical input is mediated via endocannabinoids. |
2012 |
J. Physiol. (Lond.) |
pmid:22411015
|
Hofmann ME et al. |
Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism. |
2011 |
J. Physiol. (Lond.) |
pmid:21646412
|
Hashimotodani Y et al. |
Acute inhibition of diacylglycerol lipase blocks endocannabinoid-mediated retrograde signalling: evidence for on-demand biosynthesis of 2-arachidonoylglycerol. |
2013 |
J. Physiol. (Lond.) |
pmid:23858009
|
Lindgren CA et al. |
Cyclooxygenase-2, prostaglandin E2 glycerol ester and nitric oxide are involved in muscarine-induced presynaptic enhancement at the vertebrate neuromuscular junction. |
2013 |
J. Physiol. (Lond.) |
pmid:23818695
|
Frazier CJ |
Preformed vs. on-demand: molecular economics of endocannabinoid signalling. |
2013 |
J. Physiol. (Lond.) |
pmid:24085490
|
Straiker A and Mackie K |
Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. |
2005 |
J. Physiol. (Lond.) |
pmid:16179366
|
Sang N et al. |
PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. |
2006 |
J. Physiol. (Lond.) |
pmid:16484297
|
Straiker A and Mackie K |
Metabotropic suppression of excitation in murine autaptic hippocampal neurons. |
2007 |
J. Physiol. (Lond.) |
pmid:17110416
|
Yoshino H et al. |
Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. |
2011 |
J. Physiol. (Lond.) |
pmid:21807615
|
Di S et al. |
Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. |
2005 |
J. Physiol. (Lond.) |
pmid:16239276
|
Alger BE |
Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know. |
2012 |
J. Physiol. (Lond.) |
pmid:22289914
|
Fino E et al. |
Distinct coincidence detectors govern the corticostriatal spike timing-dependent plasticity. |
2010 |
J. Physiol. (Lond.) |
pmid:20603333
|
Haj-Dahmane S and Shen RY |
Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons. |
2010 |
J. Physiol. (Lond.) |
pmid:20498231
|
Gamelin FX et al. |
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity. |
2016 |
J. Physiol. Biochem. |
pmid:26880264
|
McCarron RM et al. |
Endothelial-mediated regulation of cerebral microcirculation. |
2006 |
J. Physiol. Pharmacol. |
pmid:17244945
|
Wang M et al. |
Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. |
2012 |
J. Psychopharmacol. (Oxford) |
pmid:21890595
|
Almeida-Santos AF et al. |
2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex. |
2017 |
J. Psychopharmacol. (Oxford) |
pmid:28440729
|
Tsurumura T and Tsuge H |
Substrate selectivity of bacterial monoacylglycerol lipase based on crystal structure. |
2014 |
J. Struct. Funct. Genomics |
pmid:24894647
|
Ishii Y et al. |
F2-isoprostanes and 2-arachidonylglycerol as biomarkers of lipid peroxidation in pigs with hepatic ischemia/reperfusion injury. |
2010 |
J. Surg. Res. |
pmid:19439322
|
Baldassarri S et al. |
The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB1/CB2 receptors. |
2008 |
J. Thromb. Haemost. |
pmid:18647220
|
Kurihara J et al. |
2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves. |
2001 |
Jpn. J. Pharmacol. |
pmid:11676206
|
Lecru L et al. |
Cannabinoid receptor 1 is a major mediator of renal fibrosis. |
2015 |
Kidney Int. |
pmid:25760323
|
Martin BR et al. |
Discovery and characterization of endogenous cannabinoids. |
1999 |
Life Sci. |
pmid:10462059
|
Di Marzo V |
Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. |
1999 |
Life Sci. |
pmid:10462065
|
Bouchard JF et al. |
Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart. |
2003 |
Life Sci. |
pmid:12586223
|
Hassanzadeh P et al. |
Application of carbon nanotubes as the carriers of the cannabinoid, 2-arachidonoylglycerol: Towards a novel treatment strategy in colitis. |
2017 |
Life Sci. |
pmid:27888115
|
Forsell PK et al. |
Metabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferases. |
2012 |
Lipids |
pmid:22684912
|
Di Marzo V et al. |
Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments. |
1999 |
Lipids |
pmid:10419192
|
Alvheim AR et al. |
Dietary linoleic acid elevates the endocannabinoids 2-AG and anandamide and promotes weight gain in mice fed a low fat diet. |
2014 |
Lipids |
pmid:24081493
|
Brose SA et al. |
Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation. |
2016 |
Lipids |
pmid:27021494
|
Naccarato M et al. |
Possible Anandamide and Palmitoylethanolamide involvement in human stroke. |
2010 |
Lipids Health Dis |
pmid:20470384
|
Berge K et al. |
Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men. |
2013 |
Lipids Health Dis |
pmid:23706001
|
Koppel J et al. |
Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study. |
2009 |
Lipids Health Dis |
pmid:19144193
|
Quartu M et al. |
Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion. |
2017 |
Lipids Health Dis |
pmid:28103941
|
Caraceni P et al. |
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis. |
2010 |
Liver Int. |
pmid:19840245
|
Ying-Ying Y and Lin HC |
Endocannabinoids and non-endocannabinoid fatty acid amides in cirrhosis. |
2010 |
Liver Int. |
pmid:20408944
|
Gabbay E et al. |
Endocannabinoids and liver disease--review. |
2005 |
Liver Int. |
pmid:16162147
|
Piyanova A et al. |
Age-related changes in the endocannabinoid system in the mouse hippocampus. |
2015 |
Mech. Ageing Dev. |
pmid:26278494
|
Brellenthin AG et al. |
Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels. |
2017 |
Med Sci Sports Exerc |
pmid:28319590
|
Pryor SR |
Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal. |
2000 |
Med. Hypotheses |
pmid:11090297
|
Schlabritz-Loutsevitch N et al. |
Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity. |
2016 |
Med. Hypotheses |
pmid:27959272
|
Zareie P et al. |
Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures. |
2018 |
Metab Brain Dis |
pmid:29504066
|
Kudalkar SN et al. |
Assay of Endocannabinoid Oxidation by Cyclooxygenase-2. |
2016 |
Methods Mol. Biol. |
pmid:27245906
|
Jung KM and Piomelli D |
Assay of Monoacylglycerol Lipase Activity. |
2016 |
Methods Mol. Biol. |
pmid:27245902
|
van Zadelhoff G and van der Stelt M |
Oxygenation of Anandamide by Lipoxygenases. |
2016 |
Methods Mol. Biol. |
pmid:27245907
|
Bisogno T |
Assay of DAGLα/β Activity. |
2016 |
Methods Mol. Biol. |
pmid:27245901
|
Battista N and Sergi M |
Determination of 2-Arachidonoylglycerol by μSPE-LC-MS/MS. |
2016 |
Methods Mol. Biol. |
pmid:27245888
|
Tanikawa T et al. |
Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice. |
2007 |
Microbiol. Immunol. |
pmid:17951991
|
Bari M et al. |
New insights into endocannabinoid degradation and its therapeutic potential. |
2006 |
Mini Rev Med Chem |
pmid:16515464
|
Marco EM and Viveros MP |
The critical role of the endocannabinoid system in emotional homeostasis: avoiding excess and deficiencies. |
2009 |
Mini Rev Med Chem |
pmid:19929814
|
Ramos JA et al. |
Therapeutic potential of the endocannabinoid system in the brain. |
2005 |
Mini Rev Med Chem |
pmid:16026307
|
Gurwitz D and Kloog Y |
Do endogenous cannabinoids contribute to HIV-mediated immune failure? |
1998 |
Mol Med Today |
pmid:9612798
|
Becker TM et al. |
Endocannabinoid-dependent disinhibition of orexinergic neurons: Electrophysiological evidence in leptin-knockout obese mice. |
2017 |
Mol Metab |
pmid:28580289
|